Literature DB >> 18724358

Regulatory networks define phenotypic classes of human stem cell lines.

Franz-Josef Müller1, Louise C Laurent, Dennis Kostka, Igor Ulitsky, Roy Williams, Christina Lu, In-Hyun Park, Mahendra S Rao, Ron Shamir, Philip H Schwartz, Nils O Schmidt, Jeanne F Loring.   

Abstract

Stem cells are defined as self-renewing cell populations that can differentiate into multiple distinct cell types. However, hundreds of different human cell lines from embryonic, fetal and adult sources have been called stem cells, even though they range from pluripotent cells-typified by embryonic stem cells, which are capable of virtually unlimited proliferation and differentiation-to adult stem cell lines, which can generate a far more limited repertoire of differentiated cell types. The rapid increase in reports of new sources of stem cells and their anticipated value to regenerative medicine has highlighted the need for a general, reproducible method for classification of these cells. We report here the creation and analysis of a database of global gene expression profiles (which we call the 'stem cell matrix') that enables the classification of cultured human stem cells in the context of a wide variety of pluripotent, multipotent and differentiated cell types. Using an unsupervised clustering method to categorize a collection of approximately 150 cell samples, we discovered that pluripotent stem cell lines group together, whereas other cell types, including brain-derived neural stem cell lines, are very diverse. Using further bioinformatic analysis we uncovered a protein-protein network (PluriNet) that is shared by the pluripotent cells (embryonic stem cells, embryonal carcinomas and induced pluripotent cells). Analysis of published data showed that the PluriNet seems to be a common characteristic of pluripotent cells, including mouse embryonic stem and induced pluripotent cells and human oocytes. Our results offer a new strategy for classifying stem cells and support the idea that pluripotency and self-renewal are under tight control by specific molecular networks.

Entities:  

Mesh:

Year:  2008        PMID: 18724358      PMCID: PMC2637443          DOI: 10.1038/nature07213

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  25 in total

1.  Cell culture. Progenitor cells from human brain after death.

Authors:  T D Palmer; P H Schwartz; P Taupin; B Kaspar; S A Stein; F H Gage
Journal:  Nature       Date:  2001-05-03       Impact factor: 49.962

2.  Derivation of embryonic stem-cell lines from human blastocysts.

Authors:  Chad A Cowan; Irina Klimanskaya; Jill McMahon; Jocelyn Atienza; Jeannine Witmyer; Jacob P Zucker; Shunping Wang; Cynthia C Morton; Andrew P McMahon; Doug Powers; Douglas A Melton
Journal:  N Engl J Med       Date:  2004-03-03       Impact factor: 91.245

3.  Metagenes and molecular pattern discovery using matrix factorization.

Authors:  Jean-Philippe Brunet; Pablo Tamayo; Todd R Golub; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-11       Impact factor: 11.205

4.  BG01V: a variant human embryonic stem cell line which exhibits rapid growth after passaging and reliable dopaminergic differentiation.

Authors:  Xianmin Zeng; Jia Chen; Ying Liu; Yongquan Luo; Thomas C Schulz; Allan J Robins; Mahendra S Rao; William J Freed
Journal:  Restor Neurol Neurosci       Date:  2004       Impact factor: 2.406

5.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring.

Authors:  T R Golub; D K Slonim; P Tamayo; C Huard; M Gaasenbeek; J P Mesirov; H Coller; M L Loh; J R Downing; M A Caligiuri; C D Bloomfield; E S Lander
Journal:  Science       Date:  1999-10-15       Impact factor: 47.728

Review 6.  Characterization and differentiation of human embryonic stem cells.

Authors:  M K Carpenter; E Rosler; M S Rao
Journal:  Cloning Stem Cells       Date:  2003

7.  Gene expression profiles at diagnosis in de novo childhood AML patients identify FLT3 mutations with good clinical outcomes.

Authors:  Norman J Lacayo; Soheil Meshinchi; Paivi Kinnunen; Ron Yu; Yan Wang; Christianna M Stuber; Lorrie Douglas; Romina Wahab; David L Becton; Howard Weinstein; Myron N Chang; Cheryl L Willman; Jerald P Radich; Robert Tibshirani; Yaddanapudi Ravindranath; Branimir I Sikic; Gary V Dahl
Journal:  Blood       Date:  2004-07-13       Impact factor: 22.113

Review 8.  Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development.

Authors:  Charles E Murry; Gordon Keller
Journal:  Cell       Date:  2008-02-22       Impact factor: 41.582

9.  Isolation and characterization of neural progenitor cells from post-mortem human cortex.

Authors:  Philip H Schwartz; Peter J Bryant; Tannin J Fuja; Hailing Su; Diane K O'Dowd; Henry Klassen
Journal:  J Neurosci Res       Date:  2003-12-15       Impact factor: 4.164

10.  A genome-wide study of gene activity reveals developmental signaling pathways in the preimplantation mouse embryo.

Authors:  Q Tian Wang; Karolina Piotrowska; Maria Anna Ciemerych; Ljiljana Milenkovic; Matthew P Scott; Ronald W Davis; Magdalena Zernicka-Goetz
Journal:  Dev Cell       Date:  2004-01       Impact factor: 12.270

View more
  179 in total

1.  Molecular profiling of cytomegalovirus-induced human CD8+ T cell differentiation.

Authors:  Kirsten M L Hertoghs; Perry D Moerland; Amber van Stijn; Ester B M Remmerswaal; Sila L Yong; Pablo J E J van de Berg; S Marieke van Ham; Frank Baas; Ineke J M ten Berge; René A W van Lier
Journal:  J Clin Invest       Date:  2010-11       Impact factor: 14.808

2.  RNA-binding protein L1TD1 interacts with LIN28 via RNA and is required for human embryonic stem cell self-renewal and cancer cell proliferation.

Authors:  Elisa Närvä; Nelly Rahkonen; Maheswara Reddy Emani; Riikka Lund; Juha-Pekka Pursiheimo; Juuso Nästi; Reija Autio; Omid Rasool; Konstantin Denessiouk; Harri Lähdesmäki; Anjana Rao; Riitta Lahesmaa
Journal:  Stem Cells       Date:  2012-03       Impact factor: 6.277

3.  Small molecules enable highly efficient neuronal conversion of human fibroblasts.

Authors:  Julia Ladewig; Jerome Mertens; Jaideep Kesavan; Jonas Doerr; Daniel Poppe; Finnja Glaue; Stefan Herms; Peter Wernet; Gesine Kögler; Franz-Josef Müller; Philipp Koch; Oliver Brüstle
Journal:  Nat Methods       Date:  2012-04-08       Impact factor: 28.547

4.  The proteomes of native and induced pluripotent stem cells.

Authors:  Martin F Pera
Journal:  Nat Methods       Date:  2011-09-29       Impact factor: 28.547

5.  New meta-analysis tools reveal common transcriptional regulatory basis for multiple determinants of behavior.

Authors:  Seth A Ament; Charles A Blatti; Cedric Alaux; Marsha M Wheeler; Amy L Toth; Yves Le Conte; Greg J Hunt; Ernesto Guzmán-Novoa; Gloria Degrandi-Hoffman; Jose Luis Uribe-Rubio; Gro V Amdam; Robert E Page; Sandra L Rodriguez-Zas; Gene E Robinson; Saurabh Sinha
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-12       Impact factor: 11.205

6.  Corepressor for element-1-silencing transcription factor preferentially mediates gene networks underlying neural stem cell fate decisions.

Authors:  Joseph J Abrajano; Irfan A Qureshi; Solen Gokhan; Aldrin E Molero; Deyou Zheng; Aviv Bergman; Mark F Mehler
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-07       Impact factor: 11.205

7.  Putting stem cells to the test.

Authors:  Elie Dolgin
Journal:  Nat Med       Date:  2010-12       Impact factor: 53.440

Review 8.  REST and CoREST are transcriptional and epigenetic regulators of seminal neural fate decisions.

Authors:  Irfan A Qureshi; Solen Gokhan; Mark F Mehler
Journal:  Cell Cycle       Date:  2010-11-15       Impact factor: 4.534

Review 9.  Toward a complete in silico, multi-layered embryonic stem cell regulatory network.

Authors:  Huilei Xu; Christoph Schaniel; Ihor R Lemischka; Avi Ma'ayan
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010 Nov-Dec

Review 10.  Important precautions when deriving patient-specific neural elements from pluripotent cells.

Authors:  Xuejun H Parsons; Yang D Teng; Evan Y Snyder
Journal:  Cytotherapy       Date:  2009       Impact factor: 5.414

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.